Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Diplomat Pharmacy Inc    DPLO

DIPLOMAT PHARMACY INC

(DPLO)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector news

Diplomat Pharmacy : to Present at Investor Conferences in February, March 2019

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/12/2019 | 08:11am EDT

FLINT, Mich., Feb. 12, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO) executives will participate in four upcoming investor conferences.

Diplomat Specialty Pharmacy (PRNewsFoto/Diplomat Pharmacy, Inc.)

Brian Griffin, chairman and CEO, and Atul Kavthekar, chief financial officer, will represent the company at these events:

  • 8th Annual SVB Leerink Global Healthcare Conference in New York: Feb. 27 at 9 a.m. ET
  • Raymond James 40th Annual Institutional Investors Conference in Orlando: March 4 at 4 p.m. ET
  • Cowen and Company 39th Annual Health Care Conference in Boston: March 11 at 1:30 p.m. ET
  • Barclays Global Healthcare Conference in Miami: March 14 at 8:30 a.m. ET

Live audio webcasts of each presentation will be available on the investor relations section of Diplomat's website at ir.diplomat.is. Audio recordings will be available online for approximately 30 days following each presentation.

To learn more about Diplomat, visit diplomat.is.

About Diplomat

Diplomat (NYSE: DPLO) is the nation's largest independent provider of specialty pharmacy and infusion services. Diplomat helps people with complex and chronic health conditions in all 50 states, partnering with payers, providers, hospitals, manufacturers, and more. Rooted in this patient care expertise, Diplomat also serves payers through CastiaRx, a leading specialty benefit manager, and offers tailored solutions for healthcare innovators through EnvoyHealth. Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: "Take good care of patients and the rest falls into place." Today, that tradition continues — always focused on improving patient care. For more information, visit diplomat.is.

CONTACT:
Terri Anne Powers, Vice President of Investor Relations
312.889.5244 | tpowers@diplomat.is

Elizabeth Carr, Corporate Communications Manager
810.768.9871 | press@diplomat.is

Cision
View original content to download multimedia:http://www.prnewswire.com/news-releases/diplomat-to-present-at-investor-conferences-in-february-march-2019-300794033.html

SOURCE Diplomat Pharmacy, Inc.


© PRNewswire 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on DIPLOMAT PHARMACY INC
04:34aDPLO DEADLINE : Pawar Law Group Announces a Securities Class Action Lawsuit Agai..
AQ
04/17DIPLOMAT PHARMACY : to Release First-Quarter 2019 Operating Results May 7, Parti..
PR
04/15DPLO CLASS ACTION REMINDER : Hagens Berman Reminds Diplomat Pharmacy (DPLO) of S..
PR
04/10DIPLOMAT PHARMACY : Expands AdhereTech Relationship as Program Shows Increased A..
PR
04/10Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Di..
PR
04/09DIPLOMAT PHARMACY : Grants Chief Financial Officer Dan Davison Inducement Awards..
PR
04/05Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Fi..
BU
03/29DIPLOMAT PHARMACY ClaimsFiler Reminds Investors with Losses in Excess of $100..
BU
03/27SCOTT+SCOTT ATTORNEYS AT LAW LLP : Alerts Investors to Securities Class Actions ..
BU
03/25DEADLINE REMINDER : The Law Offices of Howard G. Smith Reminds Investors of Loom..
BU
More news